Is Laparoscopic Excision for Peritoneal Endometriosis Helpful or Harmful?
Launched by UNIVERSITY OF AARHUS · Dec 6, 2021
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether a surgical procedure called laparoscopic excision can help women with peritoneal endometriosis manage their pelvic pain. In this study, participants will be randomly assigned to one of three groups: one group will undergo the surgery to remove the endometrial tissue, another group will have the surgery but not the removal of tissue, and the third group will be on a waiting list for the procedure. The researchers will also look at how this surgery affects the participants' overall quality of life and any nerve-related pain they may experience.
To join the trial, women must be at least 18 years old and have been experiencing significant pelvic pain (rated at least a 5 out of 10) for the month before they sign up. However, women with other health issues causing pelvic pain or those who cannot read or speak Danish will not be eligible. Participants can expect to contribute to important research that may help improve treatments for endometriosis while also receiving care for their pain. The study is currently recruiting participants, providing an opportunity for those interested to learn more about their condition and potential treatment options.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult (≥ 18 years) with suspected peritoneal endometriosis undergoing elective surgery for pain relief
- • Pain intensity ≥ 5 on Numeric Rating Scale (NRS) in the four weeks prior to giving consent
- Exclusion Criteria:
- • Other known conditions/diseases that may cause pelvic pain
- • Diagnosed personality disorder, schizophrenia or treatment with anti-psychotics
- • Planned pregnancy during study period
- • Women who cannot read or speak Danish
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Horsens, Central Jutland Region, Denmark
Aarhus N, , Denmark
Herning, , Denmark
Randers, , Denmark
Viborg, , Denmark
Patients applied
Trial Officials
Axel Forman, PhD, MD
Study Director
Aarhus University, Aarhus University Hospital, Denmark
Henrik Marschall, MSc
Principal Investigator
University of Aarhus
Dorthe K Thomsen, PhD
Study Chair
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials